AEON Biopharma (AEON) Return on Assets (2021 - 2026)
AEON Biopharma (AEON) posted Return on Assets of 0.05% for Q4 2025, down 11445.23% sequentially from 0.0% in Q3 2025, and down 17.0% YoY from 0.07% in Q4 2024.
AEON Biopharma (AEON) Return on Assets (2021 - 2026) Analysis & Trends
AEON Biopharma has reported Return on Assets for 5 years, with the latest figure at 0.05% in Q4 2025.
- Quarterly Return on Assets fell 17.0% year-over-year to 0.05% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.05% (down 17.0% YoY) and the FY2025 annual result came in at 0.07%, down 16.0% from the prior year.
- Return on Assets fell to 0.05% in Q4 2025 per AEON's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.2% in Q1 2025 and troughed at 0.87% in Q1 2024.
- A 5-year average of 0.09% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2024 and 2025: Return on Assets sank 84 bps in 2024, then surged 107 bps in 2025.
- Over 5 years, Return on Assets stood at 0.0% in 2021, then plunged by 4696 bps to 0.0% in 2022, then tumbled by 9565 bps to 0.27% in 2023, then jumped by 144 bps to 0.12% in 2024, then sank by 146 bps to 0.05% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 0.05%, 0.0%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 0.00% |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - | -0.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.09% |
| Dec 31, 2025 | -0.05% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.20% |
| Dec 31, 2024 | 0.12% |
| Sep 30, 2024 | 0.08% |
| Jun 30, 2024 | -0.57% |
| Mar 31, 2024 | -0.87% |
| Dec 31, 2023 | -0.27% |
| Sep 30, 2023 | -0.19% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |